tiprankstipranks
Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
Holding BDTX?
Track your performance easily

Black Diamond Therapeutics (BDTX) Income Statement

855 Followers

Black Diamond Therapeutics Income Statement

Last quarter (Q3 2024), Black Diamond Therapeutics's total revenue was $989.00K, an increase of Infinity% from the same quarter last year. In Q3, Black Diamond Therapeutics's net income was $-15.56M. See Black Diamond Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.06M$ 1.14M----
Cost of Revenue
------
Gross Profit
$ 2.39M$ 1.14M----
Operating Expense
$ 81.36M$ 86.46M$ 92.83M$ 126.87M$ 69.57M$ 29.33M
Operating Income
$ -81.36M$ -86.46M$ -92.83M$ -126.87M$ -69.57M$ -29.33M
Net Non Operating Interest Income Expense
$ -1.92M$ -1.92M$ -2.03M-$ -1.00K-
Other Income Expense
$ -2.15M$ 2.09M$ -372.00K$ -1.28M$ -2.32M$ 5.93M
Pretax Income
$ -73.10M$ -82.44M$ -91.17M$ -125.60M$ -67.25M$ -35.26M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
--$ -2.25M---
Net Income Common Stockholders
$ -73.10M$ -82.44M$ -91.17M$ -125.60M$ -67.25M$ -35.26M
Basic EPS
$ -1.33$ -1.88$ -2.52$ -3.47$ -2.05-
Diluted EPS
$ -1.33$ -1.88$ -2.52$ -3.47$ -2.05$ -16.99
Basic Average Shares
$ 215.35M$ 43.95M$ 36.33M$ 36.19M$ 32.91M$ 2.08M
Diluted Average Shares
$ 215.35M$ 43.95M$ 36.33M$ 36.19M-$ 2.08M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 81.36M$ 86.46M$ 92.83M$ 126.87M$ 69.57M$ 29.33M
Net Income From Continuing And Discontinued Operation
$ -73.10M$ -82.44M$ -91.17M$ -125.60M$ -67.25M$ -35.26M
Normalized Income
$ -53.15M-----
Interest Expense
------
EBIT
$ -73.10M$ -82.44M$ -92.83M$ -126.87M$ -67.25M$ -35.26M
EBITDA
$ -72.75M$ -82.00M$ -92.32M$ -126.67M$ -67.20M$ -35.21M
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis